+25.5%
GSK vs LII
-32.7%
+58.2%
-18.6%
Performance
Returns, benchmark comparison, and relative performance.
Performance by timeframe
Returns for 1y.
| Period | Portfolio | LII | Excess | Alpha |
|---|---|---|---|---|
| 1D | -2.7% | -1.4% | -1.3% | -2.5% |
| 7D | -4.2% | +2.1% | -6.3% | -4.4% |
| 30D | -7.5% | -12.4% | +4.9% | -6.1% |
| 3M | -3.3% | -24.8% | +21.5% | -0.6% |
| 6M | -9.3% | -25.2% | +15.8% | -7.1% |
| YTD | +1.6% | -20.3% | +21.9% | +3.0% |
| 1Y | +25.5% | -32.9% | +58.4% | +29.4% |
| All | +25.5% | -32.7% | +58.2% | +29.4% |
Cumulative growth
Daily Returns
Daily percentage return beside LII.
Daily Out/Under-Performance
Portfolio return minus LII return. Positive bars indicate outperformance.
Daily Alpha
Portfolio daily return minus β × LII return. Early observations use the first valid beta; later observations use the trailing beta estimated for each date.
Cumulative Out/Under-Performance
Relative wealth over 1y: compounded portfolio wealth divided by compounded LII wealth, less one. Both series rebase at the selected span's start.
Cumulative Alpha
Compounded beta-adjusted residual returns apply the first valid beta to early observations, then the trailing beta ending on each date.
Updating return analytics…
1y analysis · Full analysis span regression · 6 months rolling